Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
about
Intravenous immunoglobulins for the treatment of infections in patients with haematological cancersIntravenous immunoglobulins for the treatment of infections in patients with haematological cancersMeasurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescenceTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectLipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort StudyEndotoxemia: methods of detection and clinical correlatesAntibiotic induced endotoxin release and clinical sepsis: a review.Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles.Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen.In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G.Systemic and topical immunoglobulin treatment in immunocompromised patients.Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled Trial.Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern.Endotoxaemia and inflammatory mediators in febrile patients with haematological disease.Sepsis and polyspecific intravenous immunoglobulins.Sevoflurane modulates the release of reactive oxygen species, myeloperoxidase, and elastase in human whole blood: Effects of different stimuli on neutrophil response to volatile anesthetic in vitro.IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.The Effects of Ex Vivo Administration of Granulocyte-Macrophage Colony-Stimulating Factor and Endotoxin on Cytokine Release of Whole Blood Are Determined by Priming Conditions.LPS interactions with immobilized and soluble antimicrobial peptides.Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: importance of intervention timings.Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves.Plasma endotoxin concentrations in patients with urinary tract infections.Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections
P2860
Q24186274-35F95A25-54F9-4A7B-85FA-B3783974204AQ24236448-13603D6C-67E7-45C8-AA1E-DB731855E5A7Q24801390-A905D251-6B05-4A2D-BE55-22D755E622EBQ26996658-B6DE0040-0815-48D9-975B-278A4C6DDB5FQ33384817-897917CC-1E2F-4837-81D3-C1BB17126035Q33411077-CA09C01C-7304-424C-ACEC-9E1FBE9A55A6Q33434452-D7DA9DCD-7625-404D-96DD-D8FA0C9BC88AQ34300796-7B4A19C9-9C5A-4415-871F-24BB8E10270CQ34589987-FC7DDF27-9F14-4FDC-B218-B4565D5C2D95Q35001472-FFCE7AEF-4599-4D8A-9A0C-F7FFDFBB3BB8Q36658182-8D281297-C837-48E2-AF8B-6F4F22FFE3FCQ39172391-5E349617-8199-4DB1-9535-0952DB56BE17Q39784535-4AB9295B-1643-41FC-AF95-F294767EC1BEQ40393308-77BA6E30-2898-4868-8CAB-DD66F7B056A9Q40444535-C2CAFB03-94C5-4E98-9ABA-6AB1F0604631Q40659211-0223A9BA-55E8-4C26-A202-786E2ECD676DQ40691136-8827B6AC-AECF-4AA1-9695-5BB4462056EBQ41570150-DA7D0F12-DBF7-4844-B2FC-F7526C6FD301Q46271764-489829D2-2FC2-4F59-BF79-C94A4A899FCFQ47656534-C2DE29CB-85BE-46FC-B15D-2B9095650050Q48128863-F27CB72A-C76E-4CB0-B794-C8F9266819A7Q50784302-04BBD304-D9ED-436B-98C8-B27F3F6A9BABQ51419113-4469950C-9FA5-47DB-B3C4-61FB34B1D16EQ51728254-29F9087C-9E6B-46F0-8B2C-C4984E100D39Q54604648-A3255CE7-F62E-4A6C-AE0F-5B760D843CA1Q58712827-A8A61EC7-ABA5-461C-90F9-EE966C2742EA
P2860
Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@ast
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@en
type
label
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@ast
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@en
prefLabel
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@ast
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@en
P2093
P2860
P356
P1476
Endotoxin concentration in neu ...... in M-enriched immunoglobulins.
@en
P2093
P2860
P304
P356
10.1128/AAC.36.10.2139
P407
P577
1992-10-01T00:00:00Z